(Q30229059)

11 June 2017

1 reference

title

Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready? (English)

1 reference

11 June 2017

A E Shields

1

1 reference

11 June 2017

C Lerman

series ordinal

2

1 reference

11 June 2017

language of work or name

English

0 references

publication date

5 March 2008

1 reference

Clinical Pharmacology & Therapeutics

11 June 2017

published in

1 reference

11 June 2017

volume

83

1 reference

11 June 2017

issue

4

1 reference

11 June 2017

page(s)

635-639

1 reference

Pharmacogenetics and nicotine addiction treatment

11 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

Pharmacogenomics of alcohol response and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Genetics education for primary-care providers

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Are General Practitioners Willing and Able to Provide Genetic Services for Common Diseases?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Symbiotic relationship of pharmacogenetics and drugs of abuse.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Primary care physicians' concerns about offering a genetic test to tailor smoking cessation treatment.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Will tomorrow's medicines work for everyone?

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

1 reference

7 January 2021

Skin pigmentation, biogeographical ancestry and admixture mapping

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Priorities and standards in pharmacogenetic research

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

US physicians' attitudes toward genetic testing for cancer susceptibility.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Primary care physicians who treat blacks and whites

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Confronting genetic testing disparities: knowledge is power

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000.

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

A vision for the future of genomics research

1 reference

https://api.crossref.org/works/10.1038%2FCLPT.2008.4

7 January 2021

Identifiers

DOI

10.1038/CLPT.2008.4

1 reference

11 June 2017

1 reference